Epiom, PLLC – Trademark Portfolio

Entity Type: 21

Epiom, PLLC holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include EPIOM. The owner is based in San Antonio, TX.

18756 Stone Oak Pkwy Ste 200

San Antonio, TX 782584354

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

EPIOM
EPIOM
Registered 2017

Trademark Classifications

Epiom, PLLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

44
Medical Services (1 filing)

Medical services; veterinary services; hygienic and beauty care for human beings or animals

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Epiom, PLLC have?

Epiom, PLLC has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Epiom, PLLC file in?

Epiom, PLLC files trademarks across 3 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 44 (Medical Services), Class 5 (Pharmaceuticals). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Epiom, PLLC's most well-known trademarks?

Epiom, PLLC's registered trademark portfolio includes well-known marks such as EPIOM. These are among 1 currently registered trademark in the portfolio.

What is Epiom, PLLC's trademark registration success rate?

Epiom, PLLC has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.